Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

ABBA CORD: dCBT w/ Abatacept for aGVHD Prophylaxis — Stella

Home/Acute Myelogenous Leukemia/ABBA CORD: dCBT w/ Abatacept for aGVHD Prophylaxis

View on ClinicalTrials.gov

Recruiting

Back to Acute Myelogenous Leukemia trials

ABBA CORD: dCBT w/ Abatacept for aGVHD Prophylaxis

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

United States

University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, Ohio

Key details

Phase

Safety & dosing

Sponsor

Leland Metheny

Enrollment target

~20 participants

Started

February 2025

Primary completion

October 2027

Age range

18 Years – 65 Years

Last updated June 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.